SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-018517
Filing Date
2022-12-09
Accepted
2022-12-09 16:30:25
Documents
12
Period of Report
2022-12-07
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K bpth-20221207x8k.htm   iXBRL 8-K 36078
  Complete submission text file 0001558370-22-018517.txt   155568

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpth-20221207.xsd EX-101.SCH 3072
3 EX-101.LAB bpth-20221207_lab.xml EX-101.LAB 16022
4 EX-101.PRE bpth-20221207_pre.xml EX-101.PRE 10222
6 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20221207x8k_htm.xml XML 4869
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 221455181
SIC: 2834 Pharmaceutical Preparations